These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9558070)

  • 1. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.
    Rogers PR; Grey HM; Croft M
    J Immunol; 1998 Apr; 160(8):3698-704. PubMed ID: 9558070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
    Tao X; Grant C; Constant S; Bottomly K
    J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
    Gramaglia I; Weinberg AD; Lemon M; Croft M
    J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells.
    Kimachi K; Croft M; Grey HM
    Eur J Immunol; 1997 Dec; 27(12):3310-7. PubMed ID: 9464819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of phospholipase C-gamma 1 and mitogen-activated protein kinase in naive and antigen-primed CD4 T cells by the peptide/MHC ligand.
    Ericsson PO; Orchansky PL; Carlow DA; Teh HS
    J Immunol; 1996 Mar; 156(6):2045-53. PubMed ID: 8690891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
    Croft M; Joseph SB; Miner KT
    J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance.
    Rogers PR; Croft M
    J Immunol; 1999 Aug; 163(3):1205-13. PubMed ID: 10415015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR.
    Leitenberg D; Boutin Y; Constant S; Bottomly K
    J Immunol; 1998 Aug; 161(3):1194-203. PubMed ID: 9686579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity.
    Krogsgaard M; Li QJ; Sumen C; Huppa JB; Huse M; Davis MM
    Nature; 2005 Mar; 434(7030):238-43. PubMed ID: 15724150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
    Abraham C; Griffith J; Miller J
    J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.
    Robertson JM; Evavold BD
    J Immunol; 1999 Aug; 163(4):1750-4. PubMed ID: 10438905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.
    Croft M; Bradley LM; Swain SL
    J Immunol; 1994 Mar; 152(6):2675-85. PubMed ID: 7908301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct observation of ligand recognition by T cells.
    Irvine DJ; Purbhoo MA; Krogsgaard M; Davis MM
    Nature; 2002 Oct; 419(6909):845-9. PubMed ID: 12397360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of antigen-specific T cells from unprimed mice: role of dexamethasone and anti-IL-10 antibodies.
    Dozmorov I; Miller RA
    Cell Immunol; 1997 Jun; 178(2):187-96. PubMed ID: 9225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4.
    Schweitzer AN; Sharpe AH
    J Immunol; 1999 Nov; 163(9):4819-25. PubMed ID: 10528182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals.
    Ariga H; Shimohakamada Y; Nakada M; Tokunaga T; Kikuchi T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2007 Oct; 122(2):210-21. PubMed ID: 17490433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands.
    Wilson DB; Pinilla C; Wilson DH; Schroder K; Boggiano C; Judkowski V; Kaye J; Hemmer B; Martin R; Houghten RA
    J Immunol; 1999 Dec; 163(12):6424-34. PubMed ID: 10586032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.